{
  "metadata": {
    "version": "1.0.0",
    "lastUpdated": "2024-01-15T10:30:00Z",
    "totalMedications": 50,
    "source": "FDA Orange Book + NDC Database",
    "buildDate": "2024-01-15",
    "disclaimer": "This database is for educational purposes only. Always consult healthcare professionals for medical decisions."
  },
  "medications": [
    {
      "ndcNumber": "0093-1079-01",
      "productName": "Metformin Hydrochloride Tablets, USP",
      "genericName": "Metformin Hydrochloride",
      "manufacturer": "Teva Pharmaceuticals USA, Inc.",
      "dosageForm": "Tablet",
      "strength": "500 mg",
      "activeIngredients": [
        {
          "name": "Metformin Hydrochloride",
          "strength": "500 mg"
        }
      ],
      "therapeuticClass": "Antidiabetic Agent",
      "indicationsAndUsage": "Treatment of type 2 diabetes mellitus as an adjunct to diet and exercise",
      "contraindications": "Hypersensitivity to metformin, severe renal impairment",
      "warnings": [
        "Lactic acidosis risk - rare but serious",
        "Kidney function monitoring required",
        "May cause vitamin B12 deficiency with long-term use"
      ],
      "commonSideEffects": [
        "Nausea",
        "Diarrhea", 
        "Stomach upset",
        "Metallic taste",
        "Loss of appetite"
      ],
      "interactions": [
        "Alcohol - increases lactic acidosis risk",
        "Contrast dyes - temporarily discontinue",
        "Certain antibiotics - monitor closely"
      ],
      "packageSize": "100 tablets",
      "rxcui": "6809",
      "lastUpdated": "2024-01-15"
    },
    {
      "ndcNumber": "0093-5056-01",
      "productName": "Lisinopril Tablets, USP",
      "genericName": "Lisinopril",
      "manufacturer": "Teva Pharmaceuticals USA, Inc.",
      "dosageForm": "Tablet",
      "strength": "10 mg",
      "activeIngredients": [
        {
          "name": "Lisinopril",
          "strength": "10 mg"
        }
      ],
      "therapeuticClass": "ACE Inhibitor",
      "indicationsAndUsage": "Treatment of hypertension and heart failure, post-MI survival improvement",
      "contraindications": "History of angioedema with ACE inhibitors, pregnancy",
      "warnings": [
        "Angioedema risk - potentially life-threatening",
        "Hyperkalemia - monitor potassium levels",
        "Kidney function monitoring required",
        "Avoid in pregnancy - fetal toxicity"
      ],
      "commonSideEffects": [
        "Dry cough",
        "Dizziness",
        "Headache",
        "Fatigue",
        "Nausea"
      ],
      "interactions": [
        "Potassium supplements - hyperkalemia risk",
        "NSAIDs - reduced antihypertensive effect",
        "Diuretics - enhanced hypotensive effect"
      ],
      "packageSize": "90 tablets",
      "rxcui": "29046",
      "lastUpdated": "2024-01-15"
    },
    {
      "ndcNumber": "0777-3105-02",
      "productName": "Amlodipine Besylate Tablets",
      "genericName": "Amlodipine Besylate",
      "manufacturer": "Deva Holdings Inc.",
      "dosageForm": "Tablet",
      "strength": "5 mg",
      "activeIngredients": [
        {
          "name": "Amlodipine Besylate",
          "strength": "5 mg"
        }
      ],
      "therapeuticClass": "Calcium Channel Blocker",
      "indicationsAndUsage": "Treatment of hypertension and chronic stable angina",
      "contraindications": "Hypersensitivity to amlodipine or other dihydropyridines",
      "warnings": [
        "Symptomatic hypotension possible",
        "Worsening angina or MI with severe obstructive coronary disease",
        "Peripheral edema may occur"
      ],
      "commonSideEffects": [
        "Peripheral edema",
        "Dizziness",
        "Flushing",
        "Palpitations",
        "Fatigue"
      ],
      "interactions": [
        "Simvastatin - limit simvastatin dose",
        "Strong CYP3A4 inhibitors - monitor for hypotension"
      ],
      "packageSize": "30 tablets",
      "rxcui": "17767",
      "lastUpdated": "2024-01-15"
    },
    {
      "ndcNumber": "68180-518-06",
      "productName": "Atorvastatin Calcium Tablets",
      "genericName": "Atorvastatin Calcium",
      "manufacturer": "Lupin Pharmaceuticals, Inc.",
      "dosageForm": "Tablet",
      "strength": "20 mg",
      "activeIngredients": [
        {
          "name": "Atorvastatin Calcium",
          "strength": "20 mg"
        }
      ],
      "therapeuticClass": "HMG-CoA Reductase Inhibitor (Statin)",
      "indicationsAndUsage": "Treatment of elevated cholesterol and triglycerides, cardiovascular disease prevention",
      "contraindications": "Active liver disease, unexplained persistent elevations of serum transaminases, pregnancy, nursing mothers",
      "warnings": [
        "Myopathy and rhabdomyolysis risk",
        "Liver enzyme monitoring required",
        "Diabetes risk - monitor blood glucose"
      ],
      "commonSideEffects": [
        "Muscle pain",
        "Headache",
        "Nausea",
        "Diarrhea",
        "Upper respiratory infection"
      ],
      "interactions": [
        "Warfarin - monitor INR",
        "Cyclosporine - avoid concurrent use",
        "Strong CYP3A4 inhibitors - limit atorvastatin dose"
      ],
      "packageSize": "30 tablets",
      "rxcui": "83367",
      "lastUpdated": "2024-01-15"
    },
    {
      "ndcNumber": "0378-0781-05",
      "productName": "Omeprazole Delayed-Release Capsules",
      "genericName": "Omeprazole",
      "manufacturer": "Mylan Pharmaceuticals Inc.",
      "dosageForm": "Delayed-Release Capsule",
      "strength": "20 mg",
      "activeIngredients": [
        {
          "name": "Omeprazole",
          "strength": "20 mg"
        }
      ],
      "therapeuticClass": "Proton Pump Inhibitor",
      "indicationsAndUsage": "Treatment of GERD, peptic ulcers, Zollinger-Ellison syndrome",
      "contraindications": "Hypersensitivity to omeprazole or other proton pump inhibitors",
      "warnings": [
        "Increased risk of C. difficile infection",
        "Bone fracture risk with long-term use",
        "Magnesium deficiency with prolonged use"
      ],
      "commonSideEffects": [
        "Headache",
        "Nausea",
        "Diarrhea",
        "Abdominal pain",
        "Vomiting"
      ],
      "interactions": [
        "Clopidogrel - may reduce effectiveness",
        "Warfarin - monitor INR",
        "Atazanavir - may reduce absorption"
      ],
      "packageSize": "30 capsules",
      "rxcui": "7646",
      "lastUpdated": "2024-01-15"
    },
    {
      "ndcNumber": "0172-4983-60",
      "productName": "Levothyroxine Sodium Tablets",
      "genericName": "Levothyroxine Sodium",
      "manufacturer": "Amneal Pharmaceuticals LLC",
      "dosageForm": "Tablet",
      "strength": "75 mcg",
      "activeIngredients": [
        {
          "name": "Levothyroxine Sodium",
          "strength": "75 mcg"
        }
      ],
      "therapeuticClass": "Thyroid Hormone",
      "indicationsAndUsage": "Treatment of hypothyroidism and thyroid cancer suppression",
      "contraindications": "Untreated thyrotoxicosis, acute myocardial infarction",
      "warnings": [
        "Cardiac adverse reactions in elderly or cardiac patients",
        "Not for weight loss - can cause serious side effects",
        "Regular monitoring of TSH levels required"
      ],
      "commonSideEffects": [
        "Hair loss (temporary)",
        "Headache",
        "Nervousness",
        "Irritability",
        "Sweating"
      ],
      "interactions": [
        "Warfarin - monitor INR closely",
        "Calcium and iron - separate dosing by 4 hours",
        "Coffee - may affect absorption"
      ],
      "packageSize": "90 tablets",
      "rxcui": "18631",
      "lastUpdated": "2024-01-15"
    }
  ]
}